COVID-19 complicated by postinfectious bronchiolitis obliterans and pulmonary aspergillosis in an infant.

Pediatric PulmonologyEarly View CLINICAL CORRESPONDENCE COVID-19 complicated by postinfectious bronchiolitis obliterans and pulmonary aspergillosis in an infant Thanuja Krishnananthan MBBS, Corresponding Author Thanuja Krishnananthan MBBS [email protected] orcid.org/0009-0005-5050-4834 Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia Correspondence Thanuja Krishnananthan, MBBS, Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia. Email: [email protected]Search for more papers by this authorPhilip N. Britton MBBS, Hons, PhD, Philip N. Britton MBBS, Hons, PhD Department of Infectious Diseases and Microbiology, the Children's Hospital at Westmead, Westmead, Australia Sydney Medical School, Sydney Infectious Diseases, University of Sydney, Sydney, AustraliaSearch for more papers by this authorMelanie Wong MBBS, Hons, PhD, Melanie Wong MBBS, Hons, PhD Department of Clinical Immunology and Allergy, The Children's Hospital at Westmead, Westmead, AustraliaSearch for more papers by this authorHiran Selvadurai MBBS, Hons, PhD, Hiran Selvadurai MBBS, Hons, PhD Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia Contribution: Writing - review & editing, SupervisionSearch for more papers by this author Thanuja Krishnananthan MBBS, Corresponding Author Thanuja Krishnananthan MBBS [email protected] orcid.org/0009-0005-5050-4834 Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia Correspondence Thanuja Krishnananthan, MBBS, Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia. Email: [email protected]Search for more papers by this authorPhilip N. Britton MBBS, Hons, PhD, Philip N. Britton MBBS, Hons, PhD Department of Infectious Diseases and Microbiology, the Children's Hospital at Westmead, Westmead, Australia Sydney Medical School, Sydney Infectious Diseases, University of Sydney, Sydney, AustraliaSearch for more papers by this authorMelanie Wong MBBS, Hons, PhD, Melanie Wong MBBS, Hons, PhD Department of Clinical Immunology and Allergy, The Children's Hospital at Westmead, Westmead, AustraliaSearch for more papers by this authorHiran Selvadurai MBBS, Hons, PhD, Hiran Selvadurai MBBS, Hons, PhD Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, Australia Contribution: Writing - review & editing, SupervisionSearch for more papers by this author First published: 23 June 2023 https://doi.org/10.1002/ppul.26572Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Jerkic SP, Brinkmann F, Calder A, et al. Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report. Can Respir J. 2020; 2020: 1-16. 2 World Health Organisation. Corticosteroids for COVID-19: living guidance [Internet]. MAGICapp. 2020. Accessed November 23, 2022. https://wwvw.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1 3Quadery SR, John T, Sinha P, et al. Cotrimoxazole in hospitalised patients with severe COVID-19- interim results from the CoTroxCov study. Eur Respir J. 2022; 60(66): 1544. 4Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2006 Sept 1; 174(5): 566-570. 5Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection 2021; 49(5): 833-853. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation